Advanced Search
CHENG-Bo, ZHANG Ai-min, MA Fu-jun, LI Shu-guang, HU Hai-long, LIU Li-wei, HAN Ru-fa. Diagnosis and Treatment of Renal Pelvis Carcinoma (Report of 92 Cases)[J]. Cancer Research on Prevention and Treatment, 2011, 38(08): 933-936. DOI: 10.3971/j.issn.1000-8578.2011.08.020
Citation: CHENG-Bo, ZHANG Ai-min, MA Fu-jun, LI Shu-guang, HU Hai-long, LIU Li-wei, HAN Ru-fa. Diagnosis and Treatment of Renal Pelvis Carcinoma (Report of 92 Cases)[J]. Cancer Research on Prevention and Treatment, 2011, 38(08): 933-936. DOI: 10.3971/j.issn.1000-8578.2011.08.020

Diagnosis and Treatment of Renal Pelvis Carcinoma (Report of 92 Cases)

More Information
  • Received Date: August 08, 2010
  • Revised Date: April 28, 2011
  • ObjectiveTo discuss the diagnostic and therapeutic methods of renal pelvic carcinoma. MethodsWe retrospectively analyzed the clinical and follow-up data of 92 patients with renal pelvic carcinoma.52 cases were male.Mean age was 64 years ranged from 41 to 82 years. Carcinoma was located at left in 49 cases and right in 43 cases.All patients were treated surgically. 73 cases were open nephroureterectomy with bladder cuff excision (20 cases of T1~2,group A), and 19 cases were nephroureterectomy with of bladder cuff excision using retroperitoneal laparoscopy plus transurethral resection (19 cases of T1~2,group B). ResultsOne time positive of the urine cytology was 68 cases (73.9%),and three times positive was 29 cases (31.5%). Ratios of final diagnosis of renal pelvic carcinoma by intravenous pyelogram (IVU),B ultrasound and computed tomography (CT) were 38.6%(32/83), 78.4%(69/88)and 84.6%(66/78),respectively.The pathological type of 82 cases was transitional cell carcinoma,and of 10 cases was squamous cell carcinoma with transitional cell carcinoma.According to WHO grade, 15 cases was grade Ⅰ,56 cases was grade Ⅱ and 21 cases was gradeⅢ.TNM clinical stages were 55 cases with stage Ⅰ,7 cases with stage Ⅱ 22 cases withstage Ⅲ and8 cases with stageⅣ.100% cases were followed up and mean follow-up time was 38.5 months, ranged from 3 to 60 months.The 3-year and 5-year survival rates of stage Ⅰ~Ⅱ cases were 77.4% and 54.8%,respectively and significantly higher than those of stage Ⅲ~Ⅳ cases (26.7% and 13.3%,respectively), P<0.05.In group B,blood loss during operation,postoperative drainage, intestinal function,recovery after operation,hospital stay,transfusion and use of anodyne were significantly reduced than those in group A (P<0.05),while the tumor size and operating time were no significantly different (P>0.05) between two groups. ConclusionsHematuria was the most common symptom of renal pelvic carcinoma.Urine cytology,IVU and B ultrasound should be used as a routine examination for renal pelvic carcinoma. Retrograde pyelography or CT might be a useful adjuvant examination when IVU showed negative results.Early diagnosis and treatment of renal pelvic carcinoma were critical for long-term survival.Nephroureterectomy with bladder cuff excision was the preferred treatment,although retroperitoneal laparoscopy plus transurethral resection afforded an improved postoperative course with minimal invasion,fast recovery . The effective cancer control for patient with Ⅰ~Ⅱ stage tumor was similar between 2 surgical methods.
  • Related Articles

    [1]KONG Yan, DONG Qian, LI Shuguang, XU Jinrui, ZHAO Xiaohan, DENG Wenzhao, SHEN Wenbin. Influence of Local Tumor Factors and Radiotherapy Dose on Prognosis of Clinical Stage T1-4N0M0 Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2025, 52(3): 225-232. DOI: 10.3971/j.issn.1000-8578.2025.24.0721
    [2]XIA Lili, ZHU Xinyi, ZHANG Xiwei, LI Zhengjiang, LIU Shaoyan, LU Haizhen, AN Changming. Predictive Value of Depth of Invasion of Tongue Squamous Cell Carcinoma for Cervical Lymph Node Metastasis and Prognosis[J]. Cancer Research on Prevention and Treatment, 2022, 49(7): 675-681. DOI: 10.3971/j.issn.1000-8578.2022.21.1460
    [3]LI Haiyan, ZHOU Xuan, CHEN Yunqing, JI Huihui, SHI Weiping, WANG Chengqin, XIANG Fenggang. Expression of KIF3A in Different Gastric Mucosal Lesions, Metastatic Lymph Nodes and Its Relationship with Metastasis and Prognosis of Gastric Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2018, 45(12): 985-990. DOI: 10.3971/j.issn.1000-8578.2018.18.0627
    [4]ZHAO Ruihua, JIANG Wenjing, ZHANG Weijie, CAO Xinguang. Metastasis?associated Lung Adenocarcinoma Transcript1(MALAT1) Expression in Middle Thoracic Esophageal Squamous Cell Cancer Tissues and Its Relationship with Prognosis[J]. Cancer Research on Prevention and Treatment, 2015, 42(12): 1227-1230. DOI: 10.3971/j.issn.1000-8578.2015.12.012
    [5]LV Minhao, QIN Li, LI Juntao, GUO Xuhui, LIU Fawen, CUI Shude, ZHANG Hengwei. 原发性乳腺癌分子分型与新辅助化疗疗效及预后的相关性[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 782-788. DOI: 10.3971/j.issn.1000-8578.2015.08.007
    [6]Zhen Chanjun, Zhou Zhiguo, Song Yuzhi, Qiao Xueying. Analysis of Therapeutic Effect and Prognosis of Radiotherapy for Patients with Esophageal Carcinoma with Supraclavicular Lymph Node Metastasis[J]. Cancer Research on Prevention and Treatment, 2013, 40(01): 90-94. DOI: 10.3971/j.issn.1000-8578.2013.01.023
    [7]LI Na, LI Shan-shan, ZHANG Hong-yan, XUAN Xiao-yan, ZHENG Xian-zhao, WANG Feng, YAN Ai-hua. Effects of KISS-1 Transfection on Tumor Growth of Nude Mice[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 136-140. DOI: 10.3971/j.issn.1000-8578.2010.02.004
    [8]LI Na, LI Shan-shan, ZHANG Hong-yan, XUAN Xiao-yan, ZHENG Xian-zhao, WANG Feng, YAN Ai-hua. Construction of Eukaryotic Expression Plasmid pcDNA3.1-KISS-1 and Its Metastasis Inhibiting Effect to EC1 Cells[J]. Cancer Research on Prevention and Treatment, 2009, 36(04): 265-269. DOI: 10.3971/j.issn.1000-8578.2009.04.002
    [9]GAO Zhao-hua. Analysis of Clinicopathologic Characteristics and Prognosis of Colorectal Cancer without Lymph Node Metastasis[J]. Cancer Research on Prevention and Treatment, 2008, 35(04): 272-274. DOI: 10.3971/j.issn.1000-8578.2697
    [10]Huang jinqiu, . The significance of tumor angiogenesis in the invasion metastasis and judging the prognosis of gastric carcinoma[J]. Cancer Research on Prevention and Treatment, 1998, 25(6): 441-444.

Catalog

    Article views (3498) PDF downloads (448) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return